Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a Phase 1/2 Clinical Trial of DARE-HRT1 Intravaginal Rings

<p>DARE-HRT1 Demonstrated Preliminary Treatment Efficacy for Both Vasomotor Symptoms (VMS) and Genitourinary Syndrome of Menopause (GSM) The North American Menopause Society (NAMS) Guidance on Hormone Therapy States that Dosing Estrogen and Progestogen in Combination May Offer Important Benefits to Women, and NAMS Observed that Non-Oral Routes of Administration May offer Advantages Over Orally Administered Therapies […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/dare-bioscience-announces-publication-in-the-journal-of-the-north-american-menopause-society-of-positive-efficacy-findings-for-the-treatment-of-menopausal-symptoms-from-a-phase-1-2-clinical-trial-of-d/">Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a Phase 1/2 Clinical Trial of DARE-HRT1 Intravaginal Rings</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>